Experimental Autoimmune Encephalomyelitis

Myelin Biology and Disorders

Volumn 2, Issue , 2004, Pages 1039-1071

  Lassmann, Hans ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23844516586     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012439510-7/50096-6     Document Type: Chapter

References (188)

1. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., Probert L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendrogliopathy. Amer. J. Pathol. 1998, 153:801-813.
2. Albina J.E., Henry W.L. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J Surg Res. 1991, 50:403-409.
3. Alvord E.C. Acute disseminated encephalomyelitis and "allergic" encephalopathies. Handbook of Clinical Neurology 1970, Vol. 9:500-571. Elsevier, Boca Raton, FL. P.I. Vinken, G.W. Bruyn (Eds.).
4. Alvord E.C. Species restricted encephalitogenic determinants. Experomental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis 1984, 523-537. Alan R. Liss, New York. E.C. Alvord, M.W. Kies, A.J. Suckling (Eds.).
5. Anthony D.C., Miller K.M., Fearn S., Townsend M.J., Opdenakker G., Wells G.M., Clements J.M., Chandler S., Gearing A.J., Perry V.H. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol. 1998, 87:62-72.
6. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci. 2001, 4:1116-1122.
7. Bachmann R., Eugster H.P., Frei K., Fontana A., Lassmann H. Impaiment of TNF-receptor 1 signalling but not Fas-signalling diminishes T-cell apoptosis in MOG-peptide induced chronic demyelinating autoimmune encephalomyelitis in mice. Amer J Pathol 1999, 154:1417-1422.
8. Bauer J., Bradl M., Hickey W.F., Forss-Petter S., Breitschopf H., Linington C., Wekerle H., Lassmann H. T cell apoptosis in inflammatory brain lesions. Destruction of T cells does not depend on antigen recognition. Am J Pathol 1998, 153:715-724.
9. Bechmann I., Lossau S., Steiner B., Mor G., Gimsa U., Nitsch R. Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration. Glia. 2000, 32:25-41.
10. Ben Nun A., Wekele H., Cohen I.R. The rapis isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 1981, 11:195-199.
11. Berger T., Weerth S., Kojima K., Linington C., Wekerle H., Lassmann H. Experimental autoimmune encephalomyelitis: The antigen specificity of T-lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 1997, 76:355-364.
12. Besser M., Wank R. Cutting edge: Clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J Immunol. 1999, 162:6303-6306.
13. Bhardwaj V., Kumar V., Geysen H.M., Sercarz E.E. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. J Immunol. 1993, 151:5000-5010.
14. Bielefeldt K., Whiteis C.A., Chapleau M.W., Abboud F.M. Nitric oxide enhances slow inactivation of voltage-dependent sodium currents in rat nodose neurons. Neurosci Lett. 1999, 271:159-162.
15. Blakemore W.F., Keirstead H.S. The origin of remyelinating cells in the central nervous system. J Neuroimmunol. 1999, 98:69-76.
16. Bolanos J.P., Almeida A., Stewart V., Peuchen S., Land J.M., Clark J.B., Heales S.J. Nitric oxide-mediated mitochondrial damage in the brain: Mechanisms and implications for neurodegenerative diseases. J Neurochem. 1997, 68:2227-2240.
17. Bornstein M.B., Appel S.H. The application of tissue culture to the study of experimental "allergic" encephalomyelitis. I. Patterns of demyelination. J. Neuropathol. Exp. Neurol. 1961, 20:141-147.
18. Brosnan C.F., Cammer W., Norton W.T., Bloom B.R. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature. 1980, 285:235-237.
19. Brosnan C.F., Stoner G.L., Bloom B.R., Wisniewski H.M. Studies on demyelination by activated lymphocytes in the rabbit eye. II. Antibody dependent cell mediated demyelination. J. Immunol. 1977, 118:2103-2111.
20. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science 1996, 272:60-66.
21. Cannella B., Hoban C.J., Gao Y.L., Garcia-Arenas R., Lawson D., Marchionni M., Gwynne D., Raine C.S. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc Natl Acad Sci US 1998, 95:10100-10105.
22. Chase W.M.A. A critique of attempts at passive transfer of sensitivity to nervous tissue. Allergic Encephalomyelitis 1959, 348-374. Thomas, New York. M. Kies, E. Alvord (Eds.).
23. Clements J.M., Cossins J.A., Wells G.M., Corkill D.J., Helfrich K., Wood L.M., Pigott R., Stabler G., Ward G.A., Gearing A.J., Miller K.M. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor. J Neuroimmunol. 1997, 74:85-94.
24. Cornet A., Savidge T.C., Cabarrocas J., Dend W.L., Colombel J.F., Lassmann H., Desreumaux P., Liblau R.S. Enterocolitis induced by autoimmune targeting of enteric glia cells: A possible mechanism in Crohn's disease?. Proc Natl Acad Sci (USA) 2001, 98:13306-13311.
25. Cuzner M.L., Opdenakker G. Plasminogen activators and matrix metalloproteinases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 1999, 94:1-14.
26. Dahlmann I., Wallstrom E., Weissert R., Storch M., Kornek B., Jacobsson L., Linington C., Luthman H., Lassmann H., Olsson T. Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum Mol Genet 1999, 8:2183-2190.
27. DiBello I.C., Dawson M.R., Levine J.M., Reynolds R. Generation of oligodendroglial progenitors in acute inflammatory demyelinating lesions of the rat brain stem is associated with demyelination rather than inflammation. J. Neurocytol. 1999, 28:365-381.
28. Diemel L.T., Copelman C.A., Cuzner M.L. Macrophages in CNS remyelination: Friend or foe?. Neurochem-Res. 1998, 23:341-347.
29. D'Souza S., Alinauskas K., McCrea E., Goodyer C., Antel J.P. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci. 1995, 15:7293-7300.
30. Dubois-Dalcq M., Niedieck B., Buyse M. Action of anti-cerebroside sera on myelinated nervous tissue cultures. Pathologica Europea 1970, 5:331-347.
31. Encinas J.A., Weiner H.L., Kuchroo V.K. Inheritance of susceptibility to experimental autoimmune encephalomyelitis. J Neurosci Res. 1996, 45:655-669.
32. Engelhardt B., Conley F.K., Butcher E.C. Cell adhesion molecules on vessels during inflammation in the mouse central nervous system. J Neuroimmunol. 1994, 51:199-208.
33. Eugster H.P., Frei K., Bachmann R., Bluethmann H., Lassmann H., Fontana A. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 1999, 29:626-632.
34. Evans C.F., Horwitz M.S., Hobbs M.V., Oldstone M.B. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med. 1996, 184:2371-2384.
35. Fabry Z., Raine C.S., Hart M.N. Nervous tissue as an immune compartment: The dialect of the immune response in the CNS. Immunol Today. 1994, 15:218-224.
36. Fife B.T., Huffnagle G.B., Kuziel W.A., Karpus W.J. CC chemokine receptor 2 is critical for induction of experiemntal autoimmune encephalomyelitis. J. Exp. Med. 2000, 192:899-905.
37. Fife B.T., Paniagua M.C., Lukcs N.W., Kunkel S.L., Karpus W.J. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis. J. Neurosci. Res. 2001, 66:705-714.
38. Fischer H.G., Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 2001, 166:2717-2726.
39. Flugel A., Berkowicz T., Ritter T., Labeur M., Jenne D.E., Li Z., Ellwart J.W., Willem M., Lassmann H., Wekerle H Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001, 14:547-560.
40. Flugel A., Matsumoro K., Neumann H., Klinkert W.E., Birnbacher R., Lassmann H., Otten U., Wekerle H Anti inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: Inhibition of monocyte transendeothelial migration. Eur J Immunol 2001, 13:11-22.
41. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol. 1987, 17:1271-1278.
42. Freund J., Lipton M.M., Morrison L.R. Demyelination in the guinea pig chronic allergic encephalomyelitis produced by injecting guinea pig brain in oil emulsion containing a variant of mycobacterium butyricum. Arch. Pathol. 1950, 50:108-121.
43. Genain C.P., Abel K., Belmar N., Villinger F., Rosenberg D.P., Linington C., Raine C.S., Hauser S.L. Late complications of immune deviation therapy in a non-human primate. Science 1996, 274:2054-2057.
44. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Autoantibodies to MOG mediate myelin damage in MS. Nat. Med. 1999, 5:170-175.
45. Gijbels K., Galardy R.E., Steinman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest. 1994, 94:2177-2182.
46. Gijbels K., Proost P., Masure S., Carton H., Billiau A., Opdenakker G. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res. 1993, 36:432-440.
47. Godiska R., Chantry D., Dietsch G.N., Gray P.W. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 1995, 58:167-176.
48. Gold R., Hartung H.P., Lassmann H. T-cell apoptosis in autoimmune diseases: Termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci 1997, 20:399-404.
49. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synapse: A molecular machine controlling T cell activation. Science 1999, 285:221-227.
50. Haase C.G., Guggenmos J., Brehm U., Andersson M., Olsson T., Reindl M., Schneidewind J.M., Zettl U.K., Heidenreich F., Berger T., Wekerle H., Hohlfeld R., Linington C. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J Neuroimmunol. 2001, 114:220-225.
51. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., van-Der-Meide P.H., Cullheim S., Olsson T., Piehl F. Neuroprotection by encephalomyelitis: Rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci. 2000, 20:5283-5291.
52. Hickey W.F., Hsu B.L., Kimura H. T lymphocyte entry into the central nervous system. J Neurosci Res 1991, 28:254-260.
53. Hickey W.F., Kimura H. Perivascular microglia cells of the CNS are bone marrow derived and present antigen in vivo. Science 1988, 239:290-293.
54. Hickey W.F., Osborn J.F., Kirby W.W. Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis. Cell. Immunol. 1985, 91:528-535.
55. Hickey W.F., Vass K., Lassmann H. Bone marrow derived elements in the central nervous system: An immunohistochemical and ultrastructural survey of rat chimeras. J Neuropath Exp Neurol 1992, 51:246-256.
56. Hohlfeld R. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and persectives, Brain 1997, 120:865-916.
57. Huang D., Han Y., Rani M.R., Glabinski A., Trebst C., Sorensen T., Tani M., Wang J., Chien P., O'Bryan S., Bielecki B., Zhou Z.L., Majumder S., Ransohoff R.M. Chemokines and chemokine receptors in inflammation of the nervous system: Manifold roles and exquisite regulation. Immunol Rev. 2000, 177:52-67.
58. Huitinga I., Damoiseaux J.G., Dopp E.A., Dijkstra C.D. Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats. Eur J Immunol. 1993, 23:709-715.
59. Huitinga I., Rooijen N., deGroot C.J.A., Uitdehaag B.M.J., Dijkstra C.D. Suppression of experimental allergic encephalomyelitis after elimination of macrophages. J. Exp. Med. 1990, 172:1025-1033.
60. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., Goverman J. A pathogenic role for myelin-specific CD8 (+) T cells in a model for multiple sclerosis. J Exp Med 2001, 194:669-676.
61. Issazadeh S., Ljungdahl A., Höjeberg B., Mustafa M., Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: Dynamics of mRNA expression for interleukin 10, interleukin 12, cytolysin, tumor necrosis factor a and tumor necrosis factor β. J Neuroimmunol. 1995, 61:205-212.
62. Issazadeh S., Mustafa M., Ljungdahl A., Hojeberg B., Dagerlind A., Elde R., Olsson T. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: Dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res. 1995, 40:579-590. 1995.
63. Izikson L., Klein R.S., Charo I.F., Weiner H.L., Iuster A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR) 2. J. Exp. Med. 2000, 192:1075-1080.
64. Jankovic B., Draskoci M., Janjic M. Passive transfer of "allergic" encephalomyelitis with anti-brain serum, injected into the lateral ventricle of the brain. Nature 1965, 207:428-429.
65. Jee Y., Yoon W.K., Okura Y., Tanuma N., Matsumoto Y. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats. J. Neuroimmunol. 2002, 128:49-57.
66. + T cells in murine experimental allergic encephalomyelitis. Science 1992, 256:1213-1215.
67. Kapoor R., Davies M., Smith K.J. Temporary axonal conduction block and axonal loss in inflammatory neurological disease. A potential role for nitric oxide?. Ann N Y Acad Sci. 1999, 893:304-308.
68. Kassiotis G., Pasparakis M., Kollias G., Probert L. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis. Eur J Immunol. 1999, 29:774-780.
69. Kennedy K.J., Strieter R.M., Kunkel S.L., Lucas N.W., Karpus W.J. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1. J. Neuroimmunol. 1998, 92:98-108.
70. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation?. J Exp Med. 1999, 189:865-870.
71. Kies M.W., Murphy J.B., Alvord E.C. Fractionation of guinea pig brain proteins with encephalitogenic activity. Fed. Proc. 1960, 19:207.
72. Kim Y.S., Kim S.U. Oligodendroglial cell death induced by oxygen radicals and its protection by catalase. J Neurosci Res. 1991, 29:100-106.
73. Koh D.R., Fung-Leung W.P., Ho A., Gray D., Acha-Orbea H., Mak T.W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8 -/- mice. Science 1992, 256:1210-1213.
74. Kojima K., Berger Th., Lassmann H., Hinze-Selch D., Zhang Y., Germann J., Reske K., Wekerle H., Linington C. Experimental autoimmune panencephalitis and uveoretinitis transfered to the Lewis rat by T-lymphocytes specific for the S100ß molecule, a calcium binding protein of astroglia. J Exp Med 1994, 180:817-829.
75. Korner H., Lemckert F.A., Chaudhri G., Etteldorf S., Sedgwick J.D. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur J Immunol. 1997, 27:1973-1981.
76. Kotter M.R., Setzu A., Sim F.J., Van-Rooijen N., Franklin R.J. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia. 2001, 35:204-212.
77. Kubes P., Suzuki M., Granger D.N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991, 88:4651-4655.
78. Lafaille J. The role of Helper T cell subsets in autoimmune disease. Cytokine & Growth Factor Reviews 1998, 9:139-151.
79. Lafaille J.J., Keere F.V., Hsu A.L., Baron J.L., Haas W., Raine C.S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient bosts rather than protect them from disease. J. Exp. Med. 1997, 186:307-312.
80. Lassmann H. Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis 1983, Springer, Springfield, IL.
81. Lassmann H., Brunner C., Bradl M., Linington C. Experimental allergic encephalomyelitis: The balance between encephalitogenic T-lymphocytes and demyelinating antibodies determines size ans structure of demyelinated lesions. Acta Neuropathol. 1988, 75:566-576.
82. Lassmann H., Kitz K., Wisniewski H.M. In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin. Acta. Neuropathol. 1981, 55:297-306.
83. Lebar R., Lubetzki C., Vincent C., Lombrail P., Poutry J.M. The MS autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membranes. Experimental Immunol. 1986, 66:423-443.
84. Lee S.J., Benveniste E.N. Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 1999, 98:77-88.
85. Leppert D., Waubant E., Burk M.R., Oksenberg J.R., Hauser S.L. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis. Ann Neurol. 1996, 40:846-852.
86. Lieberman A.P., Pitha P.M., Shin H.S., Shin M.L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 1989, 86:6348-6352.
87. Linington C., Berger Th., Perry L., Weerth S., Hinze-Selch D., Zhang Y., Lu H., Lassmann H., Wekerle H. T cells specific for the myelin oligodendroglia glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 1993, 23:1364-1372.
88. Linington C., Bradl M., Lassmann H., Brunner C., Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating antibodies against a myelin oligodendrocyte glycoprotein. Amer. J. Pathol. 1988, 130:443-454.
89. Linington C., Engelhardt B., Kapocs G., Lassmann H. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol. 1992, 40:219-224.
90. Linington C., Lassmann H. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: Correlation of serum demyelinating activity with the antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol 1987, 17:61-69.
91. Linker R.A., Maurer M., Gaupp S., Martini R., Holtmann B., Giess R., Rieckmann P., Lassmann H., Toyka K.V., Sendtner M., Gold R. CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation. Nat Med. 2002, 8:620-624.
92. Lipton S.A. Neuronal injury associated with HIV-1: Approaches and treatment. Annu Rev Pharmacol Toxicol 1998, 38:159-177.
93. Litzenburger T., Fässler R., Bauer J., Lassmann H., Linington C., Wekerle H., Iglesias A. B lymphocytes producing demyelinating antibodies: Development and function in gene-trageted transgenic mice. J Exp Med 1998, 188:169-180.
94. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., Bernard C.C. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med. 1998, 4:78-83.
95. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 1998, 338:436-445.
96. Maatta J.A., Kaldman M.D., Sakoda S., Salmi A.A., Hinkkanen A.E. Encephalitogenicity of myelin associated oligodendrocytic basic protein and 2',3'-cyclic nucleotide 3'-phosphodieserase for BALB/c and SJL mice. Immunology 1998, 95:383-388.
97. Maeda H., Okamoto T., Akaike T. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol Chem. 1998, 379:193-200.
98. Matsui M., Weaver J., Proudfoot A.E.I., Wujek J.R., Wei T., Richter E., Trapp B.D., Rao A., Ransohoff R.M. Treatment of experiemntal autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES. J. Neuroimmunol. 2002, 128:16-22.
99. Matsumoto Y., Fujiwara M. In situ detection of class I and II major histocompatibility complex antigens in the rat central nervous system during experimental allergic encephalomyelitis. An immunohistochemical study. J Neuroimmunol. 1986, 12:265-277.
100. McMorris F.A., McKinnon R.D. Regulation of oligodendrocyte development and CNS myelination by growth factors: Prospects for therapy of demyelinating disease. Brain Pathol. 1996, 6:313-329.
101. McRae B.L., Vanderlugt C.L., Dal-Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med. 1995, 182:75-85.
102. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol. 1993, 151:2132-2141.
103. Miller S.D., Eagar T.N. Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases. Adv Exp Med Biol. 2001, 490:99-107.
104. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Dal-Canto M.C., Bluestone J.A. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995, 3:739-745.
105. Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I.R., Schwartz M. Production of neurotrophins by activated T cells: Implications for neuroprotective autoimmunity. J Autoimmun. 2000, 15:331-345.
106. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med. 1999, 5:49-55.
107. Mokhtarian F., McFarlin D.E., Raine C.S. Adoptive transfer of myelin basic protein-sensitized T cells produce chronic relapsing demyelinating disease in mice. Nature 1984, 309:356-358.
108. Mokhtarian F., Zhang Z., Shi Y., Gonzales E., Sobel R.A. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J Neuroimmunol. 1999, 95:43-54.
109. Moody D.B., Besra G.S. Glycolipid targets of CD1-mediated T-cell responses. Immunology 2001, 104:243-251.
110. Moody D.B., Besra G.S., Wilson I.A., Porcelli S.A. The molecular basis of CD1-mediated presentation of lipid antigens. Immunol. Reviews 1999, 172:285-296.
111. Morris-Downes M.M., McCormack K., Baker D., Sivaprasad D., Natkunarajah J., Amor S. Encephalitogenic and immunogenic potential of myelin associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) in ABH and SJL mice. J Neuroimmunol. 2002, 122:20-33.
112. Neumann H., Boucraut J., Hahnel C., Misgeld T., Wekerle H. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur J Neurosci. 1996, 8:2582-2590.
113. Neumann H., Medana I.M., Bauer J., Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS disease. Trends Neurosci. 2002, 25:313-319.
114. Neumann H., Misgeld T., Matsumuro K., Wekerle H. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: Involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci US 1998, 95:5779-5784.
115. Neumann H., Schmidt H., Cavalie A., Jenne D., Wekerle H. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: Differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. J Exp Med. 1997, 185:305-316.
116. Niehaus A., Shi J., Grzenkowski M., Diers-Fenger M., Hartung H.P., Toyka K., Bruck W., Trotter J Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: Implications for remyelination. Ann Neurol. 2000, 48:362-371.
117. Noble P.G., Antel J.P., Yong V.W. Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes. Brain Res. 1994, 633:83-90.
118. Numao T., Agrawal D.K. Neuropeptides modulate human eosinophil chemotaxis. J. Immunol. 1992, 149:3309-3315.
119. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J Neuroimmunol. 1997, 73:107-116.
120. Oldstone M.B., Southern P.J. Trafficking of activated cytotoxic T lymphocytes into the central nervous system: Use of a transgenic model. J Neuroimmunol. 1993, 46:25-31.
121. Olsson T., Dahlman I., Wallstrom E., Weissert R., Piehl F. Genetics of rat neuroinflammation. J. Neuroimmunol. 2000, 107:191-200.
122. Opdenakker G., Van-Damme J. Cytokine-regulated proteases in autoimmune diseases. Immunol Today. 1994, 15:103-107.
123. Owens T., Wekerle H., Antel J. Genetic models for CNS inflammation. Nature Med. 2001, 7:161-166.
124. Paterson P.Y. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. Exp. Med. 1960, 111:119-135.
125. Pender M.P., Nguyen K.B., McCombe P.A., Kerr J.F. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci. 1991, 104:81-87.
126. Pender M.P, Rist M.J. Apoptosis of inflammatory cells in immune control of the nervous system: Role of glia. Glia. 2001, 36:137-144.
127. Piddlesden S.J., Storch M., Hibbs M., Freeman A.M., Lassmann H., Morgan B.P. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol 1994, 152:5477-5484.
128. Pitt D., Werner P., Raine C.S. Glutamate excitotoxicity in a model of multiple sclerosis. Nature Med 2000, 6:67-70.
129. Prineas J.W., McDonald I.W. Demyelinating diseases. Greenfield's Neuropathology 1997, 813-896. Arnold, Berlin, Heidelberg, New York. 6th ed. D.I. Graham, P.L. Lantos (Eds.).
130. Probert L., Eugster H.P., Akassoglou K., Bauer J., Frei K., Lassmann H., Fontana A. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain. 2000, 123:2005-2019.
131. Raine C.S. Experimental allergic encephalomyelitis and experimental allergic neuritis. Handbook of Clinical Neurology 1985, Vol. 47:429-466. Elsevier, London, Sidney, Auckland. P.I. Vinken, G.W. Bruyn (Eds.).
132. Raine C.S., Snyder D.H., Valsamis M.D., Stone S.H. Chronic experimental allergic encephalomyelitis in inbred guinea pigs-an ultrastructural study. Lab. Invest. 1974, 31:369-380.
133. Ransohoff R.M. Mechanisms of inflammation in MS tissue: Adhesion molecules and chemokines. J Neuroimmunol 1999, 98:57-68.
134. Remlinger P. Les paralysies due traitment antirebique. Annals of the Institute Pasteur 1928, 55:35-68. (Suppl).
135. Rivers T.M., Sprunt D.H., Berry G.P. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. Exp. Med. 1933, 58:39-53.
136. Rodriguez M., Miller D.J. Immune promotion of central nervous system remyelination. Prog-Brain-Res. 1994, 103:343-355.
137. Rosener M., Muraro P.A., Riethmuller A., Kalbus M., Sappler G., Thompson R.J., Lichtenfels R., Sommer N., McFarland H.F., Martin R. 2',3'-cyclic nucleotide 3'-phosphodiesterase: A novel candidate autoantigen in demyelinating diseases. J Neuroimmunol 1997, 75:28-34.
138. Ruff M., Wahl S.M., Pert C.B. Substance P receptor mediated chemotaxis of human monocytes. Peptide 1985, 6:107-111.
139. Ruffini F., Furlan R., Poliani P.L., Brambilla E., Marconi P.C., Bergami A., Desina G., Glorioso J.C., Comi G., Martino G. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene-Ther. 2001, 8:1207-1213.
140. Schlüsener H., Sobel R.A., Linington C., Weiner H.L. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 1987, 139:4016-4021.
141. Schmied M., Breitschopf H., Gold R., Zischler H., Rothe G., Wekerle H., Lassmann H. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: Evidence for prgrammed cell death as a mechanism to control inflammation in the brain. Amer J Pathol 1993, 143:446-452.
142. Schwartz M. Harnessing the immune system for neuroprotection: Therapeutic vaccines for acute and chronic neurodegenerative disorders. Cell Mol Neurobiol. 2001, 21:617-627.
143. Seil A.J., Quarles R.H., Johnson D., Brady R.O. Immunisation with purified myelin associated glycoprotein does not evoke myelination inhibiting or demyelinating antibodies. Brain Research 1981, 209:470-475.
144. Seil F.J., Agrawal H.C. Myelin proteolipid protein does not induce demyelinating or myelin inhibiting antibodies. Brain Research 1980, 194:273-277.
145. Selmaj K.W., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988, 23:339-346.
146. Serafini B., Columba-Cabezas S., Di Rosa F., Aloisi F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Amer J Pathol 2000, 157:1991-2002.
147. Shamshiev A., Donda A., Carena I., Mori L., Kappos L., DeLibero G. Self glycolipids as T-cell autoantigens. Eur. J. Immunol. 1999, 29:1667-1675.
148. Shamshiev A., Gober H.J., Donda A., Mazorra Z., Mori L., DeLibero G. Presentation of the same glycolipid by different CD1-molecules. J. Exp. Med. 2002, 195:1013-1021.
149. Smith T., Groom A., Zhu B., Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nature Med. 2000, 6:62-66.
150. Smith K.J., Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurology 2002, 1:232-241.
151. Smith K.J., Kapoor R., Felts P.A. Demyelination: The role of reactive oxygen and nitrogen species. Brain Pathol. 1999, 9:69-92.
152. Smith K.J., Kapoor R., Hall S.M., Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol. 2001, 49:470-476.
153. Sobel R.A., Colvin R.B. The immunopathology of experimental allergic encephalomyelitis (EAE). III. Differential in situ expression of strain 13 Ia on endothelial and inflammatory cells of (strain 2 × strain 13) F1 guinea pigs with EAE. J. Immunol. 1985, 91:2333-2337.
154. Sobel R.A., Kuchroo V.K. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions. J. Immunol. 1992, 149:1444-1451.
155. Springer T.A. Traffic signals for lymphocyte recirculation and leucocyte emigration: The multistep paradigm. Cell 1994, 76:301-314.
156. Stefferl A., Brehm U., Storch M., Lambracht-Washington D., Bourquin C., Wonigeit K., Lassmann H., Linington C. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the resistant Brown Norway rat: Disease susceptibility is determined by MHC and MHC-linked effects on the B-cell response. J Immunol 1999, 163:40-49.
157. Storch M.K., Fischer-Colbrie R., Smith T., Rinner W.A., Hickey W.F., Cuzner M.L., Winkler H., Lassmann H. Co-localization of secretoneurin immunoreactivity and macrophage infiltration in the lesions of experimental autoimmune encephalomyelitis. Neurosci. 1996, 71:885-893.
158. Storch M.K., Stefferl A., Brehm U., Weissert R., Wallström E., Kerschensteiner M., Olsson T., Linington C., Lassmann H Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998, 8:681-694.
159. Storch M.K., Weissert R., Stefferl A., Birnbacher R., Wallstrom E., Dahlman I., Ostensson C.G., Linington C., Olsson T, Lassmann H. MHC gene related effects on microglia and macrophages in experiemntal autoimmune encephalomyelitis determine the extent of axonal injury. Brain Pathol. 2002, 12:287-299.
160. Sun D., Qin Y., Chluba J., Epplen J.T., Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T-cell interactions. Nature 1988, 332:843-845.
161. Sun D., Wekerle H. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature. 1986, 320:70-72.
162. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 2001, 166:7579-7587.
163. Sundvall M., Jirholt J., Yang H.T., Jansson L., Engsröm A., Pettersson U., Holmdahl R. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nature Genetics 1995, 10:313-317.
164. Swanborg R.H. Experimental autoimmune encephalomyelitis in the rat: Lessons in T-cell immunology and autoreactivity. Immunol. Reviews 2001, 184:129-135.
165. Taupin V., Renno T., Bourbonniere L., Peterson A.C., Rodriguez M., Owens T. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system. Eur J Immunol. 1997, 27:905-913.
166. Teesalu T., Hinkkanen A.E., Vaheri A. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Am J Pathol. 2001, 159:2227-2237.
167. Traugott U., Reinherz E.L., Raine C.S. Multiple sclerosis: Distribution of T cell subsets within active chronic lesions. Science 1983, 219:308-310.
168. Tsunoda I., Kuang L.Q., Theil D.J., Fujinami R.S. Antibody association with a novel model for primary progressive multiple sclerosis: Induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol. 2000, 10:402-418.
169. Vanderlugt C.L., Begolka W.S., Neville K.L., Katz-Levy Y., Howard L.M., Eagar T.N., Bluestone J.A., Miller S.D. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Rev. 1998, 164:63-72.
170. Vass K., Heininger K., Schäfer B., Linington C., Lassmann H. Interferon-gamma potentiates antibody-mediated demyelination in vivo. Ann. Neurol. 1992, 32:189-206.
171. Vass K., Lassmann H. Intrathecal application of interferon-gamma: Progressive appearance of MHC antigens within the rat nervous system. Amer. J. Pathol. 1990, 137:789-800.
172. Voskuhl R.R. Myelin protein expression in lymphoid tissues: Implications for peripheral tolerance. Immunol Rev. 1998, 164:81-92.
173. Wallstrom E., Diener P., Ljungdahl A., Khademi M., Nilsson C.G., Olsson T. Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis. J Neurol Sci. 1996, 137:89-96.
174. Weerth S., Berger T., Lassmann H., Linington C. Encephalitogenic and neuritogenic T cell responses ti the myelin associated glycoprotein (MAG) in the Lewis rat. J Neuroimmunol. 1999, 95:157-164.
175. Weissert R., Wallstrom E., Storch M.K., Stefferl A., Lorentzen J., Lassmann H., Linington C., Olsson T. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J-Clin-Invest. 1998, 102:1265-1273.
176. Wekerle H. Immunology of multiple sclerosis. McAlpine's Multiple Sclerosis 1998, 379-407. Churchill Livingstone, New York. A. Compston (Ed.).
177. Wekerle H., Linington C., Lassmann H., Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci. 1986, 9:271-277.
178. White C.A., McCombe P.A., Pender M.P. Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95). Int Immunol. 1998, 10:935-941.
179. White C.A., Nguyen K.B., Pender M.P. B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: Roles of B cell CD95, CD95L and Bcl-2 expression. J Autoimmun. 2000, 14:195-204.
180. Willenborg D.O., Fordham S.A., Cowden W.B., Ramshaw I.A. Cytokines and murine autoimmune encephalomyelitis: Inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand-J-Immunol. 1995, 41:31-41.
181. Willenborg D.O., Staykova M.A., Cowden W.B. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review. J Neuroimmunol. 1999, 100:21-35.
182. Wisniewski H.M., Bloom B.R. Primary demyelination as a nonspecific consequence of a cell mediated immune reaction. J. Exp. Med. 1975, 141:346-459.
183. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995, 80:695-705.
184. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L. Prevention of experimental autoimmune encephalomyelitis by antibodies against a4ß1 integrin. Nature 1992, 356:63-66.
185. Yu M., Johnson J.M., Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease. J Exp Med. 1996, 183:1777-1788.
186. Zamvil S., Nelson P., Trotter J., Mitchell D., Knobler R., Fritz R., Steinman L. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 1985, 317:355-358.
187. Zettl U.K., Mix E., Zielasek J., Stangel M., Hartung H.P., Gold R. Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell Immunol. 1997, 178:1-8.
188. Zhang J., Dawson V.L., Dawson T.M., Snyder S.H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994, 263:687-689.